Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort-Reference-Cited by-同舟云学术

Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort

Published:2019-03-19 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Sone Kazuki,Oguri Tetsuya,Uemura Takehiro,Takeuchi Akira,Fukuda Satoshi,Takakuwa Osamu,Maeno Ken,Fukumitsu Kensuke,Kanemitsu Yoshihiro,Ohkubo Hirotsugu,Takemura Masaya,Ito Yutaka,Niimi Akio

Funder

Grant-in-Aid from Nagoya City University Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5438-2.pdf

Reference33 articles.

1. Kubota K, Watanabe K, Kunitoh H, Noda K, Ichinose Y, Katakami N, et al. Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere lung Cancer study group. J Clin Oncol. 2004;22:254–61.

2. Shukuya T, Yamanaka T, Seto T, Daga H, Goto K, Saka H, et al. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial. Lancet Oncol. 2015;16:1630–8.

3. Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, et al. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007. J Clin Oncol. 2010;28:3299–306.

4. Shepherd FA, Dancey J, Ramlau R, Mattson K, Gralla R, O'Rourke M, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol. 2000;18:2095–103.

5. Kunitoh H, Watanabe K, Onoshi T, Furuse K, Niitani H, Taguchi T. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol. 1996;14:1649–55.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer;Cancer Chemotherapy and Pharmacology;2023-10-28

2. CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer;European Journal of Cell Biology;2023-06

3. Meta-analysis of lung cancer in Chinese population in genetic predisposition;BIO Web of Conferences;2023

4. Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells;Pharmaceutics;2022-10-13

5. Network analysis reveals different hub genes and molecular pathways for pig in vitro fertilized early embryos and parthenogenotes;Reproduction in Domestic Animals;2022-08-29